Regeneron Pharmaceuticals, Inc. Achieves #40 Analyst Rank, Surpassing EOG Resources, Inc.
October 09, 2013 at 11:48 AM EDT
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Regeneron Pharmaceuticals, Inc. (REGN) has taken over the #40 spot from EOG Resources, Inc.